The results showed that the expression of both MEK1/2 and p-MEK1/2 did not change significantly (Supplementary Figure S4), indicating a different mechanism of PRKG1 in bladder cancer development. The gene discussed is MAP2K1; the disease is urinary bladder carcinoma.